Estradiol transdermal - Searchlight PharmaAlternative Names: OESCLIM
Latest Information Update: 19 Jul 2016
At a glance
- Originator Searchlight Pharma
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome
Most Recent Events
- 19 Jul 2016 Chemical structure information added
- 15 Mar 2016 Biomarkers information updated